Le Cam-Duchez V, Barbay V, Soria C, Borg J-Y
Unité d'hémostase vasculaire, hématologie biologique, hôpital Charles-Nicolle, CHU de Rouen, EA3829, groupe de recherche MERCI, institut hospitalo-universitaire de recherche biomédicale, université de Rouen, 22, boulevard Gambetta, 76183 Rouen cedex, France.
Rev Med Interne. 2010 Aug;31(8):551-7. doi: 10.1016/j.revmed.2009.04.013. Epub 2010 Apr 22.
Protein Z (PZ) is a vitamin K dependent protein acting as the cofactor of the protein Z dependent inhibitor (ZPI), in the inhibition of activated factor X bound on the phospholipids. Normal plasma protein Z concentrations have wide variations among individuals, partly explained by a genetic control. Several protein Z gene polymorphisms influence plasma concentration, separately and in combination. The role of PZ in blood coagulation regulation has been demonstrated in vitro. The responsibility of low PZ level in the occurrence of thrombosis has been questioned. However, the roles of PZ plasma level and PZ gene polymorphisms remain debated with conflicting results in arterial, venous, or placental thrombosis. These discrepancies can be explained by the heterogeneity of populations chosen as control, by the PZ interindividual variability, by the small size of the cohorts in mainly retrospective studies and perhaps by the lack of real important influence of this protein on coagulation. PZ measurement is not actually considered as a biological marker of thrombophilia. Large prospective studies remain to be done to investigate its possible role in thrombosis.
蛋白Z(PZ)是一种维生素K依赖性蛋白,在抑制结合于磷脂上的活化因子X时,作为蛋白Z依赖性抑制剂(ZPI)的辅助因子。正常血浆蛋白Z浓度在个体间存在很大差异,部分原因是受基因控制。几种蛋白Z基因多态性分别或共同影响血浆浓度。PZ在血液凝固调节中的作用已在体外得到证实。低PZ水平在血栓形成中的作用一直受到质疑。然而,在动脉、静脉或胎盘血栓形成中,PZ血浆水平和PZ基因多态性的作用仍存在争议,结果相互矛盾。这些差异可以通过所选对照组人群的异质性、PZ个体间变异性、主要回顾性研究中样本量较小以及可能该蛋白对凝血缺乏真正重要影响来解释。实际上,PZ测量并不被视为血栓形成倾向的生物学标志物。仍需进行大型前瞻性研究以调查其在血栓形成中的可能作用。